| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Dec 28, 2022 | Dec 31, 2022 | Flynn James E Possible Member of 10% Group 10% | Sell | $0.26 | $88,254 | -11.46% |
| Dec 22, 2022 | Dec 27, 2022 | Flynn James E Possible Member of 10% Group 10% | Sell | $0.27 | $19,897 | -2.44% |
| Dec 19, 2022 | Dec 22, 2022 | Flynn James E *Possible Member of 10% Group 10% | Sell | $0.29 | $37,628 | -4.09% |
| Dec 13, 2022 | Dec 15, 2022 | Flynn James E *Possible Member of 10% Group 10% | Sell | $0.39 | $5,332 | -0.44% |
| May 25, 2022 | May 25, 2022 | Wanstall Rick CFO Treasurer | Buy | $1.2 | $4,532 | +6.90% |
| May 20, 2022 | May 24, 2022 | Wanstall Rick CFO Treasurer | Buy | $1.2 | $1,932 | +3.30% |
| May 17, 2022 | May 19, 2022 | Wanstall Rick CFO Treasurer | Buy | $1.29 | $6,451 | +9.88% |
| Nov 16, 2021 | Nov 17, 2021 | Harbin Stephen COO Chief of Staff | Buy | $5.79 | $173,655 | +50.00% |
| Jun 01, 2021 | Jun 03, 2021 | Queva Christophe CSO SVP Research | Sell | $16.68 | $392,813 | -33.09% |
| Apr 30, 2021 | May 04, 2021 | Queva Christophe CSO SVP Research | Sell | $15.97 | $376,123 | -39.81% |
| Apr 26, 2021 | Apr 28, 2021 | Queva Christophe CSO SVP Research | Sell | $15.22 | $277,783 | -23.58% |
| Apr 06, 2021 | Apr 08, 2021 | Queva Christophe CSO SVP Research | Sell | $15.01 | $79,553 | -6.41% |
| Feb 17, 2021 | Feb 18, 2021 | Flynn James E *Possible Member of 10% Group 10% | Buy | $19 | $6M | +8.70% |
| Oct 06, 2020 | Oct 08, 2020 | Mpm Sunstates Fund, L.P. 10% | Buy | $15 | $3M | +5.75% |
| Oct 06, 2020 | Oct 08, 2020 | Mpm Bioventures 2014, L.P. 10% | Buy | $15 | $3M | +5.75% |
| Oct 06, 2020 | Oct 08, 2020 | Gadicke Ansbert 10% | Buy | $15 | $5M | +12.03% |
| Oct 06, 2020 | Oct 08, 2020 | Evnin Luke Dir 10% | Buy | $15 | $2M | +5.72% |
| Oct 06, 2020 | Oct 08, 2020 | Ubs Oncology Impact Fund L.P. 10% | Buy | $15 | $2M | +5.98% |
| Oct 06, 2020 | Oct 08, 2020 | Flynn James E *Possible Member of 10% Group 10% | Buy | $15 | $15M | +25.98% |